Cervical Radiculopathy
Off-label use with one RCT (Michalsen 2018) showing significant pain reduction at 7 days in cervical radiculopathy without surgical indication.
Resumen para el Paciente
- ¿Está esto autorizado por FDA para este uso?
- No — investigated off-label. The FDA cleared medicinal leeches in 2004 only for venous congestion in microsurgical reconstruction (K040187). Use for cervical radiculopathy is supported by one published trial but not FDA-evaluated.
- ¿Qué evidencia existe?
- One randomized trial (Michalsen 2018, n=66) reported that a single session of leech therapy reduced neck and arm pain at 7 days compared with conventional care, with benefit lasting at 4 weeks. The neck disability score also improved. This is a single small trial with short follow-up. Leech therapy is not appropriate when there is progressive weakness, severe nerve compression on imaging, or any sign of spinal cord involvement — those require urgent surgical evaluation.
- Riesgos principales
- Bleeding and oozing from bite sites on the neck and shoulder for several hours
- Bruising along the neck for 3 to 7 days, which can be cosmetically noticeable
- Itching, redness, and irritation at bite sites for days to weeks
- Small permanent scars on the neck or upper back
- Local skin infection or, rarely, Aeromonas infection from leech gut bacteria
- Allergic reaction to leech saliva (uncommon)
- Temporary worsening of pain or stiffness for 1 to 2 days after the session
- Quién no debería considerar esto
- Patients taking blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran, or heparin
- Patients with hemophilia or other inherited bleeding disorders
- Patients with severe anemia (hemoglobin under 10 g/dL)
- Patients with a weakened immune system
- Patients with progressive arm weakness, hand clumsiness, or balance problems (surgical evaluation needed)
- Patients with spinal cord compression on imaging (urgent surgical evaluation)
- Patients with any sign of infection near the spine
- Qué preguntar a su clínico
- Have I had an MRI, and is there a structural problem that needs surgical evaluation first?
- Am I a candidate for standard treatments — physical therapy, NSAIDs, epidural steroid injection — and have I given them a fair trial?
- What is the realistic chance leech therapy will help me, and for how long?
- What is the practitioner's experience with cervical-region leech application?
- What antibiotic plan do you use for Aeromonas prevention?
- What red flags should I and my family watch for after the session?
- What is the cost, and is it covered by insurance? (typically not)
- Cuándo buscar atención urgente
- New or worsening weakness in the arm or hand
- New numbness, tingling, or weakness in the legs, balance problems, or loss of bladder/bowel control (possible spinal cord involvement — emergency)
- Sudden severe neck pain with fever and stiff neck (possible spinal infection)
- Bleeding from a bite site lasting more than 24 hours
- Spreading redness, warmth, pus, or red streaks (cellulitis)
- Fever above 38.0 C / 100.4 F or chills
- Hives, throat tightness, or breathing difficulty
Qué NO significa esto
- It does not mean leech therapy is FDA-approved for cervical radiculopathy — it is not.
- It does not mean leech therapy fixes the underlying disc or bone problem — it may only reduce symptoms temporarily.
- It does not mean it replaces neurosurgical evaluation when there are red-flag features such as progressive weakness or spinal cord signs.
- It does not mean every patient improves — the published trial showed benefit on average, but individual responses vary.
- It does not mean improvement is permanent — long-term outcomes beyond 4 weeks are not well studied.
Referencias cruzadas de seguridad
Clinical Profile
- Category
- neurological
- ICD-10
- M50.10, M50.11, M50.12, M50.13, M54.12
- Safety tier
- medium
Evidence Summary
No randomized controlled trial or clinical study of leech therapy for cervical radiculopathy has been published. A proposed rationale, extrapolated from leech trials in other musculoskeletal pain syndromes, combines local anti-inflammatory effects with reduction of paravertebral venous congestion that may contribute to nerve-root edema, but this remains speculative. Use is investigational and is not a substitute for surgical evaluation in patients with progressive motor deficit.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)
Key Trials
- Michalsen A et al. (2018), n=66
Contraindications
- Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
- Hemophilia or other bleeding disorder
- Severe anemia (Hb <10 g/dL)
- Active bacteremia or sepsis
- Known hypersensitivity to leech salivary proteins
- Pregnancy (relative — first/third trimester)
- Immunocompromised state with severe neutropenia
- Progressive motor deficit (surgical referral)
- Spinal cord compression on imaging
- Active epidural infection
Related Conditions
Lumbar Radiculopathy (Sciatica)
Off-label use with controlled trial evidence (n=80) showing leg pain and Oswestry score improvement at 4-12 weeks in non-surgical lumbar disc disease.
Migraine
Investigational use with case-series evidence for reduction of migraine frequency and intensity; mechanism plausible via reduction of cervico-cranial venous congestion.
Tension-Type Headache
Investigational use with small case series suggesting frequency reduction in chronic tension headache via reduction of pericranial muscle tension and venous congestion.
Sciatica (Non-Discogenic / Piriformis)
Investigational use for non-discogenic sciatica including piriformis syndrome; case-series evidence for pain reduction.